Is aspirin the sole cause of stomach ulcers?

Is aspirin the sole cause of stomach ulcers?

Aspirin damages the stomach lining by blocking protective prostaglandins, raising ulcer risk, yet it is rarely the only factor. Most ulcers linked to aspirin involve simultaneous H. pylori infection, other NSAIDs, smoking, or heavy alcohol use.

What other factors combine with aspirin to trigger ulcers?

H. pylori bacteria weaken the mucosal barrier, so aspirin injury is magnified when both are present. Concurrent NSAID use adds further COX inhibition. Smoking reduces mucosal blood flow and healing speed, while alcohol directly irritates the lining. Older age and prior ulcer history also increase susceptibility.

Can aspirin alone still cause ulcers?

Yes. Daily low-dose aspirin used for cardiovascular protection produces gastric erosions and ulcers in some patients even without H. pylori. Endoscopic studies show new ulcers in roughly 5–10 % of long-term users who have none of the additional risk factors listed above.

When does the risk appear and how long does it last?

Mucosal injury can start within days of the first dose. Ulcer complications such as bleeding rise steadily with continued use and remain elevated for weeks after stopping. Patients on indefinite low-dose regimens therefore require ongoing gastro-protection if other risks are present.

What happens if someone stops aspirin because of ulcer symptoms?

Discontinuing aspirin increases cardiovascular events in those taking it for secondary prevention. Guidelines recommend continuing aspirin when possible and adding a proton-pump inhibitor or switching to enteric-coated or lower-dose forms instead of abrupt cessation.

Who makes aspirin and are patents still active?

Aspirin (acetylsalicylic acid) is long off-patent and produced generically by dozens of manufacturers worldwide. No current exclusivity blocks generic production or new formulations.

How do doctors balance ulcer risk against heart protection?

They assess individual cardiovascular risk versus gastrointestinal risk. Patients at high ulcer risk receive co-prescription of a PPI, are tested and treated for H. pylori if present, and may be switched to clopidogrel or other antiplatelet agents if aspirin intolerance persists.